Your browser doesn't support javascript.
loading
Photoswitchable Antagonists for a Precise Spatiotemporal Control of ß2-Adrenoceptors.
Duran-Corbera, Anna; Catena, Juanlo; Otero-Viñas, Marta; Llebaria, Amadeu; Rovira, Xavier.
Afiliação
  • Duran-Corbera A; MCS, Laboratory of Medicinal Chemistry, Institute for Advanced Chemistry of Catalonia (IQAC-CSIC), 08034 Barcelona, Spain.
  • Catena J; MCS, Laboratory of Medicinal Chemistry, Institute for Advanced Chemistry of Catalonia (IQAC-CSIC), 08034 Barcelona, Spain.
  • Otero-Viñas M; SiMChem, Service of Synthesis of High Added Value Molecules, Institute for Advanced Chemistry of Catalonia (IQAC-CSIC), 08034 Barcelona, Spain.
  • Llebaria A; Molecular Photopharmacology Research Group, The Tissue Repair and Regeneration Laboratory (TR2Lab), Faculty of Sciences and Technology, University of Vic-Central University of Catalonia, Vic, 08500 Barcelona, Spain.
  • Rovira X; MCS, Laboratory of Medicinal Chemistry, Institute for Advanced Chemistry of Catalonia (IQAC-CSIC), 08034 Barcelona, Spain.
J Med Chem ; 63(15): 8458-8470, 2020 08 13.
Article em En | MEDLINE | ID: mdl-32686936
ß2-Adrenoceptors (ß2-AR) are prototypical G-protein-coupled receptors and important pharmacological targets with relevant roles in physiological processes and diseases. Herein, we introduce Photoazolol-1-3, a series of photoswitchable azobenzene ß2-AR antagonists that can be reversibly controlled with light. These new photochromic ligands are designed following the azologization strategy, with a p-acetamido azobenzene substituting the hydrophobic moiety present in many ß2-AR antagonists. Using a fluorescence resonance energy transfer (FRET) biosensor-based assay, a variety of photopharmacological properties are identified. Two of the light-regulated molecules show potent ß2-AR antagonism and enable a reversible and dynamic control of cellular receptor activity with light. Their photopharmacological properties are opposite, with Photoazolol-1 being more active in the dark and Photoazolol-2 demonstrating higher antagonism upon illumination. In addition, we provide a molecular rationale for the interaction of the different photoisomers with the receptor. Overall, we present innovative tools and a proof of concept for the precise control of ß2-AR by means of light.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Compostos Azo / Receptores Adrenérgicos beta 2 / Antagonistas de Receptores Adrenérgicos beta 2 Limite: Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Compostos Azo / Receptores Adrenérgicos beta 2 / Antagonistas de Receptores Adrenérgicos beta 2 Limite: Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article